Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Nat Commun. Author manuscript; available in PMC 2014 January 19.
Published in final edited form as:
PMCID: PMC3843951

Small Molecules Enable Neurogenin 2 to Efficiently Convert Human Fibroblasts to Cholinergic Neurons


Cell fate can be reprogrammed by modifying intrinsic and extrinsic cues. Here, we show that two small molecules (forskolin and dorsomorphin) enable the transcription factor Neurogenin 2 (NGN2) to convert human fetal lung fibroblasts into cholinergic neurons with high purity (>90%) and efficiency (up to 99% of NGN2-expressing cells). The conversion is direct without passing through a proliferative progenitor state. These human induced cholinergic neurons show mature electrophysiological properties and exhibit motor neuron-like features including morphology, gene expression, and the formation of functional neuromuscular junctions. Inclusion of an additional transcription factor, SOX11 also efficiently converts postnatal and adult skin fibroblasts from healthy and diseased human patients to cholinergic neurons. Taken together, this study identifies a simple and highly efficient strategy for reprogramming human fibroblasts to subtype-specific neurons. These findings offer a unique venue for investigating the molecular mechanisms underlying cellular plasticity and human neurodegenerative diseases.

Keywords: Neurogenin 2, NGN2, SOX11, Forskolin, Dorsomorphin, Cholinergic neuron, Reprogramming


Cell fate is determined and maintained by both intrinsic and extrinsic cues1. Altering these cues can reprogram one cell type to another, as demonstrated by the direct conversion of somatic cells to functional neurons through lineage-specific transcription factors2-15. However, current reprogramming methodologies for human somatic cells requires multiple transcription factors and/or microRNAs. This process is generally inefficient and yields specific neuronal subtypes of low purity.

Signaling molecules play important roles in cell fate determination and maintenance1. We sought to test the hypothesis that these molecules can facilitate transcription factor-mediated reprogramming. We initially focused on Neurogenin 2 (NGN2), a basic helix-loop-helix transcription factor that regulates commitment of neural progenitors to neuronal fate during development and reprograms early postnatal astroglia into neurons14,16-18. NGN2 also plays a critical role in specifying motor neuron identity during spinal cord development19-22. However, NGN2 as a key factor has less been employed in neuronal reprogramming from human fetal or adult fibroblasts.

Through screening a pool of 7 small molecules, we have here defined a culture composition enabling NGN2 to efficiently convert human fetal fibroblasts to pure and functional cholinergic neurons. This basic composition consists of forskolin (FSK), an activator of cAMP signaling, and dorsomorphin (DM, also known as Compound C), an inhibitor of bone morphogenetic protein (BMP) signaling. SOX11 is an additional factor required for NGN2 to efficiently reprogram human postnatal and adult fibroblasts to highly pure cholinergic neurons under the defined culture condition.


Highly efficient conversion of human fibroblasts to neurons

We selected seven small molecules known to target signaling pathways or induce epigenetic changes important for neurogenesis and/or neuronal survival (Supplementary Table S1). Human fetal lung IMR-90 or MRC-5 fibroblasts were transduced with retrovirus expressing NGN2-IRES-GFP and treated individually with these molecules 2 days post retroviral infection (dpi) for 4 days. Transduction efficiency was estimated at 50% by GFP expression. Over a time course of 22 dpi, the neuronal marker Tuj1 was undetected in cultures treated with either vehicle or six of the small molecules. In contrast, FSK treatment resulted in extensive production of Tuj1+ cells with neuronal-like morphology in a dose-dependent manner (Fig. 1a-b and Supplementary Fig. S1). These cells appeared as early as 7 dpi and survived to 10 dpi. However, most of these cells died before developing into MAP2+ mature neurons. Therefore, we screened for additional chemicals to enhance neuronal survival. We found that DM can synergize with FSK to promote both neuronal survival and maturation, although independently DM has no effect on neuronal conversion (Fig. 1a-c). Under this defined culture condition, more than 95% of GFP+ cells expressed mature neuronal marker MAP2 by 14 dpi. In contrast, treatment with other small molecules had either no effect (RA or SB) or inhibited neuronal maturation (VPA, NaB, TSA) (Fig. 1c). Inclusion of a third chemical to the FSK and DM cocktail also failed to further enhance the reprogramming efficiency.

Figure 1
NGN2 induces rapid and efficient neuronal conversion of human fetal fibroblasts

We examined the effect of FSK and DM on neuronal induction using 36 additional candidate genes that encode transcription factors and microRNAs (Supplementary Table S2). We did not detect neuron-like Tuj1+ cells under the same culture condition (Supplementary Fig. S2). ASCL1 transduced cells infrequently resulted in Tuj1+ cells. However, these cells showed primitive unipolar or bipolar morphology and did not exhibit mature neuronal features even following extended culture beyond 30 dpi. Taken together, these data suggest that FSK and DM uniquely cooperate with NGN2 to reprogram human fetal fibroblasts to neurons.

Functional maturation of human fibroblast-derived neurons

A time course analysis of the reprogramming process showed that Tuj1+ cells began to appear at 7 dpi and sharply increased by 10 dpi. At 14 dpi, a respective 87% and 99% of the surviving NGN2-transduced IMR-90 and MRC-5 cells (indicated by GFP) became Tuj1+ neurons. This represents 56% and 234% of the initially transduced IMR-90 and MRC-5 cells, respectively (Supplementary Fig. S3a-b). The induced neurons survived over 30 days with progressive neurite outgrowth (Fig. 1d-f and Supplementary Fig. S3c). Transcriptomic analysis at 21 dpi distinctively clusters these induced neurons with neurons of the human brain and spinal cord but not the parental fibroblasts (Supplementary Fig. S4a). Highly enriched gene sets include those involved in neuron projection, synapse formation, and synaptic vesicle tethering. In contrast, markers for proliferating fibroblasts, such as genes involved in mitotic spindle formation, extracellular matrix, and collagen are dramatically downregulated (Supplementary Fig. S4b).

The reprogramming process was accompanied by a progressive appearance of neuronal morphology as indicated by round or pyramidal somas, condensed nuclei, and growth of multiple neurites and long axons (Fig. 1f). Nearly all Tuj1+ cells expressed mature neuronal markers such as MAP2, Tau, and NeuN by 14 dpi (Fig. 1g-l). After 21 dpi, more than 90% of Tuj1+ cells were also positive for glutamatergic (vGLUT1) and presynaptic (SYT1) markers in a stereotypical punctuate pattern (Fig. 1m-n). In contrast, markers for astroglia (GFAP) were undetected (Supplementary Fig. S5a) and GABAergic neurons were rarely observed (<0.1%) (Fig.1o, Supplementary Fig. S5b).

Induced neurons cultured for 50 dpi or longer displayed characteristic electrophysiological properties. A train of action potentials was elicited by injecting depolarizing current steps (Fig. 2a). Depolarizing voltage steps at −30mV and above elicited a fast inward, tetrodotoxin (TTX)-sensitive current that resembles current from voltage-dependent sodium channels in primary neurons (Fig. 2b-e). A brief puff of GABA, glycine or kainite onto these neurons also activated their respective receptors (Fig. 2f-h). Spontaneous activities were detected when co-cultured with cortical neurons (Fig. 2i). Subunits of the voltage-gated sodium (Scn3b), potassium (Kcnj6), and calcium (Cacna1h) channels that may serve to generate relevant electrical signals were robustly induced in converted neurons (Supplementary Fig. S6).

Figure 2
NGN2-induced neurons are functionally mature

Direct fate switch of human fibroblasts to neurons

While NGN2 expression itself had no major effect on the morphology or cell proliferation of human fetal fibroblasts, the addition of FSK and DM to the culture medium induced rapid morphological changes. This was confirmed by time-lapse live cell imaging for 120 hrs post-treatment with small molecules (Supplementary Fig. S7). NGN2-expressing cells (indicated by co-expressed GFP) were elongated 4 hrs post-treatment and extended neurites by 24 hrs. These morphological changes were also accompanied by a gradual reduction in cell body size. The majority of NGN2-expressing cells had morphed into neuron-like cells with long bipolar or multipolar processes and a smaller soma-like cell body by 120 hrs post-treatment.

Cell proliferation was rarely observed during live cell imaging and was further examined by BrdU-labeling experiments (Fig. 3). MRC-5 cells were transduced with retrovirus encoding GFP or NGN2-IRES-GFP and were switched to FSK- and DM-containing induction medium 40 hrs later. Proliferating cells were pulse-labeled with BrdU (10 μM) for 2 hrs before immunocytochemical analyses at 24, 48 or 72 hrs post viral infection (hpi), respectively (Fig. 3a). Around 50% of cells were BrdU-labeled at 24 hpi and this dropped to approximately 30% one day later. At 72 hpi less than 5% of cells were BrdU-labeled (Fig. 3b-c). Interestingly, no significant difference in the number of BrdU-labeled cells was observed between cells transduced with GFP or NGN2-IRES-GFP indicating treatment with small molecules rather than NGN2-expression resulted in cell cycle exit. Consistent with cell cycle exit associated with the reprogramming process, converted neurons were rarely labeled even after long-term incubation with BrdU starting from 3 dpi (one day after treatment with FSK and DM) (Fig. 3d-g). Long-term BrdU-labeling was shown as not toxic since 70% of the converted neurons could be labeled if BrdU-treatment started two days prior to the addition of FSK and DM.

Figure 3
Neuronal conversion from human fibroblasts is accompanied by cell cycle exit

Time course analysis of gene expression by qRT-PCR showed that Sox2, Olig2, and Pax6 were not detectable during the entire reprogramming process (Supplementary Fig. S8a-c). Immunocytochemistry using antibodies specific to SOX1, SOX2, and OLIG2 also showed a lack of specific staining for these markers of neural progenitors (Supplementary Fig. S8d-e). Together, these data indicate that neuronal conversion of human fibroblasts by NGN2 and small molecules is direct without passing through a proliferative progenitor intermediate.

Neuronal conversion without long-term expression of NGN2

qRT-PCR analysis revealed an induction of endogenous NGN2 and a dramatic downregulation of retroviral NGN2 beginning at 14 dpi (Fig. 4a). We used a doxycycline (Dox)-inducible system to control NGN2 expression and examined total surviving neurons at 35 dpi to temporally characterize the requirement for exogenous NGN2 (Fig. 4b-d). Quantitative analysis of gene expression showed that Dox-induced NGN2 returned to the basal level by 7 days upon Dox withdrawal (Fig. 4c). Interestingly, human fetal fibroblasts can be reprogrammed into neurons after only two days of induced NGN2 expression. The number of neurons increased with longer induction periods and reached a plateau at 21 days (Fig. 4d). In total, this data suggests that long-term expression of exogenous NGN2 is not required for neuronal conversion and survival following reprogramming.

Figure 4
Neuronal conversion from human fibroblasts does not require long-term expression of NGN2

Converted cells are highly pure cholinergic neurons

Interestingly, the converted neurons have a distinctive morphology resembling that of motor neurons (Fig. 1f). At 21 dpi, immunocytochemistry and qRT-PCR analysis for converted neurons showed specific expression of motor neuron markers including HB9 (91.7% of neurons, n=325) and ISL1/2 (90.2%, n=347), which specify motor neuron identity. ChAT (choline acetyltransferase, 98.5%, n=325) and VAChT (vesicular acetylcholine transporter, 98.2%, n=273), markers for the production and transport of acetylcholine (ACh, neurotransmitter employed by cholinergic motor neurons), were also robustly expressed (Fig. 5a-d). We therefore designated these converted neurons as human induced cholinergic neurons (hiCNs).

Figure 5
Cholinergic motor neuron-like cells converted from human fetal fibroblasts

Notably, the expression of genes for cholinergic motor neurons could be detected as early as 5 dpi reaching a peak between 14 and 21 dpi (Fig. 5e-g). SMN, a gene critical for the survival of motor neurons, was also upregulated (Fig. 5h). Markers for upper motor neurons (Fezf2)23,24 were not detected (Supplementary Fig. S9). In contrast, Hox gene expression profiles indicated that the induced motor neuron-like cells have a cervical identity (Fig. 5i)25-29. After replating, the survival of these neurons also depended on a set of neurotrophic factors (BDNF, GDNF, and NT3) essential to motor neurons (Supplementary Fig. S10)30. These hiCNs maintained their motor neuron-like identity and displayed typical electrophysiological properties 4 weeks after turning off exogenous NGN2 expression (Supplementary Fig. S11).

We co-cultured hiCNs with C2C12-derived myotubes to assess synaptic functionality. During co-culture, hiCN axons extended to form synaptic-like structures innervating the myotubes (Supplementary Fig. S12a-d). Staining with α-bungarotoxin (α-BTX) revealed clustered ACh receptors on myotubes in close contact with enlarged SYT1+ axonal terminals of hiCNs. This is indicative of the formation of neuromuscular junctions (Fig. 5j). Interestingly, myotubes frequently started to contract rhythmically 4-7 days post co-culture with hiCNs (Supplementary Movie 1). Incubation with curare, a competitive antagonist of nicotinic ACh receptors, completely blocked hiCN-induced myotube contractions (Fig. 5k and Supplementary Fig. S12e). Although myotubes cultured alone or with hiCN-conditioned medium occasionally showed spontaneous contractions, they were discontinuous, arrhythmic, and insensitive to curare-treatment. Collectively, these data suggest that hiCNs exhibit motor neuron-like functionality.

Conversion of adult human fibroblasts to cholinergic neurons

We next applied these reprogramming conditions to postnatal and adult skin fibroblasts from 3 to 37-year-old donors (Supplementary Table S3). However, neurons were generated at low efficiency suggesting requirement of an additional factor(s) (Fig. 6a). When NGN2 was combined with each of 36 additional candidate genes, only SOX11 greatly potentiated neuronal conversion from fetal (Supplementary Fig. S13), postnatal, and adult fibroblasts (Fig. 6a). We also screened for additional chemicals or growth factors and found that FGF2 could dramatically enhance reprogramming efficiency (Fig. 6a). These data are consistent with a well-established role of SOX11 and FGF2 in neurogenesis, neuronal survival, and maturation31-37. Notably, the omission of any of these identified molecules dramatically reduced reprogramming efficiency (Supplementary Fig. S14).

Figure 6
Efficient generation of cholinergic neurons from postnatal and adult human skin fibroblasts

We also found that extending the DM/FGF2 treatment from 4 days to 10 days greatly increased the conversion rate of all fibroblasts examined (Fig. 6b), though the continuous presence of these molecules were not necessary after 10 days. Under this condition, 20.3-57.2% of seeded fibroblasts were converted to Tuj1+ neurons at 21 dpi (Fig. 6b). When normalized to the number of transduced NGN2-expressing cells, the conversion rate was 77%-93% (Fig. 6c). The variable rate of viral transduction and heterogeneous nature of donor-derived primary fibroblasts are plausible contributors to this range of conversion efficiencies. Remarkably, induced neurons could be robustly generated from skin biopsies of patients with spinal muscular atrophy (SMA, GM03813, 90.8% of NGN2-expressing cells and 57.2% of seeded cells) or amyotrophic lateral sclerosis (ALS, ND29563, 87% of NGN2-expressing cells and 37.5% of seeded cells) (Fig. 6b-d), suggesting that these disease conditions did not impede neuronal conversion. The converted neurons expressed Tuj1, MAP2, and SYT1 (Fig. 6g-h). Consistent with a cholinergic phenotype of fetal hiCNs, the majority of postnatal and adult skin fibroblasts-derived neurons also expressed ChAT (81.9%-90.7%) and HB9 (78.0%-85.9%) indicating the addition of SOX11 and FGF2 did not alter the subtype of the converted neurons (Fig. 6e-f, i-j).


The ability of directly converting non-neuronal somatic cells into neurons provides a unique opportunity to understand cellular plasticity and model human neurodegenerative diseases in culture. A critical prerequisite to achieving these goals is the high-efficiency generation of a relatively homogenous population of subtype-specific neurons. Yet, the majority of currently available methods have not achieved this standard, especially in models of adult or diseased human cells. For example, motor neuron-like cells were previously generated from human embryonic stem cell-derived fibroblasts; however, as many as eight transcription factors were required and the efficiency was extremely low (<0.05% of the seeded cells)4. Screening combinations of intrinsic and extrinsic factors with potential synergistic roles in cell fate specification, we unexpectedly found that a combination of two small molecules enables the single transcription factor NGN2 to efficiently convert human fetal fibroblasts to highly pure cholinergic neurons. Inclusion of an additional transcription factor, SOX11, also efficiently converts postnatal and adult human fibroblasts to similarly pure cholinergic neurons.

A different combination of small molecules was previously used for cellular reprogramming of stably transduced human fibroblasts by ASCL1 and NGN22. The conversion efficiency is high, but the resulting culture was a mixture of GABAergic (20%), glutamatergic (35%), and a low percentage of other subtype-specific neurons. Intriguingly, none express ChAT or HB92. In stark contrast, our converted neurons from fetal, postnatal, and adult human fibroblasts exhibit motor neuron-like cholinergic features with a majority expressing ChAT (81.9%-98.5%) and HB9 (78.0%-91.7%). Several differences between our protocol and that by Ladewig et al.2 might explain the specific induction of different neuronal subtypes. First, Ladewig et al. used two factors, ASCL1 and NGN2, which have opposing roles in cell fate determination in different brain and spinal cord regions38,39. The final balance of these two opposing factors within a heterogeneous cell population might underlie the induction of a mixture of neuronal subtypes. In contrast, our use of a single cell fate-specifying factor (NGN2) in fetal fibroblasts would activate a cohesive pathway that determines a more homogenous neuronal subtype. Since SOX11 only promotes neuronal survival and maturation but does not specify neuronal subtype40-42, its inclusion in our protocol for reprogramming postnatal and adult fibroblasts does not change the neuronal subtype that is specified by NGN2. Second, in addition to BMP/SMAD signaling inhibitors (noggin and LDN-193189), Ladewig et al. also included SB431542, an Activin/Nodal/TGFβ pathway inhibitor, and CHIR99021, a GSK3β inhibitor, in their culture medium2. It has been previously shown that GSK3β is critical for phosphorylation of NGN2 and that this phosphorylation regulates motor neuron specification21. Indeed, when CHIR99021 was included in our defined condition, HB9 was no longer detectable. These data clearly show the pivotal effect of different combinations of small molecules with different transcription factors on neuronal conversion, confirming decades of research on neural development showing that neuronal identity is specified and tightly maintained by a unique combination of intrinsic and extrinsic cues. Nonetheless, additional factors might be required to further enhance the motor neuron-like phenotype of our hiCNs, since Isl1 and Lhx3, two transcription factors important for motor neuron specification43 were undetected by qRT-PCR analysis.

In summary, our results show that highly pure subtype-specific neurons can be directly converted from human fibroblasts by the coordinated action of transcription factor(s) and extrinsic cues. This is also the first case demonstrating that NGN2 as a key transcription factor, in combination with the synergistic action of two small molecules, is capable of very efficiently reprogramming human fibroblasts to cholinergic neurons under a defined culture condition. Our high efficiency reprogramming methodology provides a novel model to tease out the detailed molecular mechanisms underlying cell fate plasticity. Further optimization of the reprogramming process to obtain a homogenous population of cholinergic motor neurons from patients’ fibroblasts will significantly expedite the molecular genetic analysis of motor neuron diseases such as SMA and ALS. These induced patient-specific cholinergic neurons may also provide the most relevant cell type for drug screening and testing. One limitation of direct lineage reprogramming is the scalability of these cells for broader applications. This limitation might be overcome by the expansion of fibroblasts or the derivation of renewable neural stem cells44-48. The strategy defined here also offers a straightforward method for the discovery of novel combinations of small molecules and transcription factors for improved efficiency in reprogramming somatic cells to proliferative stem cells or other postmitotic cell lineages.


Plasmid construction and virus production

cDNA of each candidate factor (Supplementary Table S2) was individually subcloned into a retroviral vector (pLNCX2, Clontech). To monitor NGN2-expressing cells, an IRES-GFP or IRES-GFP-T2A-Sox11 cassette was inserted right after the stop codon of the NGN2 gene in plasmid pLNCX2. For doxycycline-inducible expression, NGN2-IRES-GFP was subcloned into a doxycycline-inducible lentiviral vector (iLV) under the control of pTRE3G [pLenti CMVTRE3G eGFP Puro (w819-1), Addgene] promoter. pLenti CMV rtTA3G Blast (R980-M38-658) was obtained from Addgene. Replication-incompetent retroviruses were produced in GP293 cells (Clontech) via calcium phosphate-mediated transfection of CMV-VSV-G and retroviral vectors. Similarly, lentiviruses were generated in HEK293 cells (ATCC) after co-transfection of lentiviral vector, pREV, pMDL, and pVSV-G.

Cell culture

Human fibroblasts were obtained from commercial sources (Supplementary Table S3) and maintained in fibroblast medium (DMEM supplemented with 10% or 15% fetal bovine serum and penicillin/streptomycin) according to the vendor’s instructions for cell culture. Cells were seeded onto gelatin-, fibronectin-, or Matrigel-coated culture vessels (4.8×105 per 24- or 48-well plate, or 8×105 per 10-cm dish) with or without glass cover slips. They were transduced the next day with retroviral supernatants in the presence of 6 μg/ml polybrene. After overnight incubation, culture media were refreshed. One day later, the cells were then switched to C2 medium, which consists of DMEM:F12:Neurobasal (2:2:1), 0.8% N2 (Invitrogen), 0.4% B27 (Invitrogen), and penicillin/streptomycin. Screens for small molecules were conducted by incubating the indicated chemicals (Supplementary Table S1) in C2 medium for 5 days starting at 2 days post infection (dpi). The resulting neural induction medium for human fetal fibroblasts consist of DM (1 μM, from 2 dpi to 6 dpi) and FSK (10 μM) in C2 medium. For postnatal and adult human fibroblasts, FGF2 (10 ng/ml) and DM was included in the above induction medium from 2 dpi to 12 dpi. Induction medium was half-changed every other day. For inducible expression, cells were transduced overnight with lentiviruses. The day after medium change, Dox (0.1 μg/ml) was added to induce gene expression for the indicated period of time during the course of reprogramming. For gene expression analysis, electrophysiology, or coculture with myotubes, induced neurons were purified by differential plating. Briefly, cells at 14-21 dpi were rinsed with DPBS and dissociated with 0.025% trypsin for 15 minutes at 37°C. After blocking trypsin activity with FBS-containing fibroblast medium, the cell suspension was plated onto a gelatin-coated culture dish, to which fibroblasts tightly attached. About 30 min later, floating cells, which mainly consisted of induced neurons, were replated onto a new coated dish to remove residual fibroblasts or were directly collected by centrifugation at 500 g for 2 min. Cells were resuspended into C2 medium and centrifuged again to remove cell debris. Finally, cells were plated onto a coated dish in C2 medium supplemented with BDNF, GDNF and NT3 (10 ng/ml each, Peprotech). Unless indicated otherwise, C2 media with neurotrophic factors were half-changed twice a week. The human neural stem cell line, K048, was a kind gift of Dr. P. Wu (UT Medical Branch) and Dr. C.N. Svendsen (University of Wisconsin).

Immunofluorescence, BrdU labeling and cell counting

After fixation with 4% paraformaldehyde (PFA) in PBS for 15 minutes at RT, cells were permeabilized and blocked with blocking solution (1×PBS containing 0.2% Triton X-100 and 3% BSA) for 1 hr. Primary antibodies in blocking solution were then added and incubated overnight at 4°C, followed by washing and incubation with fluorophore-conjugated corresponding secondary antibodies. Proliferating cells were labeled by BrdU (10 μM) for 2 hrs or throughout the culture, as indicated. BrdU-incorporation was detected as previously described49. Briefly, PFA-fixed cells were treated with 2 M HCl for 30 min at 37°C, rinsed in 0.1 M boric acid for 10 min, and blocked with blocking solution. This was followed by incubation with primary and secondary antibodies. The following antibodies were used: rabbit anti-NGN2 (Chemicon, 1:500), rabbit or mouse anti-Tuj1 (Covance, 1:20,000), mouse anti-MAP2 (Sigma, 1:750), chicken anti-Tau (AVES, 1:500), mouse anti-NeuN (Chemicon, 1:500), mouse anti-vGluT1 (UC Davis, 1:100), mouse anti-synaptotagmin 1 (SYT1, DSHB, 1:200), rabbit anti-GABA (Sigma, 1:2000), rabbit anti-Sox1 (Cell Signaling, 1:100), rabbit anti-Sox2 (Chemicon, 1:500), rabbit anti-Olig2 (Millipore, 1:500), mouse anti-BrdU (Sigma, 1:2000), mouse anti-HB9 (DSHB, 1:100), mouse anti-ISL1/2 (DSHB, 1:100), mouse anti-VAChT (DSHB, 1:200), goat anti-ChAT (Chemicon, 1:200), and Alexa Fluor-conjugated secondary antibodies made in donkey (Invitrogen, 1:500). Images were obtained with a Carl Zeiss LSM510 Confocal Microscope or an Olympus BX51 Microscope equipped with StereoInvestigator software (MBF Bioscience). After counting the total number of Tuj1+ cells within the entire well of a 24- or 48-well plate in triplicate, conversion efficiency was calculated by normalizing to the number of plated cells or to the number of surviving GFP+ cells.

Transcriptome and qRT-PCR analysis

Total RNAs from the indicated samples were isolated by using TRIzol Reagent (Invitrogen) and an RNA extraction kit (Zymo Research). Total RNAs from a 43-year old whole human brain and pooled total RNAs from 20-59 years old healthy humans were purchased from Clontech. Gene expression profiling using Human HT-12 v4 BeadChip (Illumina) was performed by the Microarray Core Facility at UT Southwestern. Data with an average fold change of 2 at p ≤ 0.05 for each comparison were considered for gene ontology (GO) analysis by DAVID ( qRT-PCR using independent RNA samples in triplicate was performed using SYBR Green chemistry (Invitrogen). Primer sequences are listed in Supplementary Table S4.


Reprogrammed neurons, cultured on astrocyte- or cortical neuron-coated glass coverslips for 4-6 weeks, were used for analysis. Whole-cell recordings were made under visual guidance using IR-DIC and GFP-fluorescence to identify GFP+ cells. For recordings with inducible expression of NGN2, converted neurons at 21 dpi were labeled with DiI (2 μg/ml, Invitrogen), washed, and plated on astrocyte-coated coverslips in Dox-free neuronal culture medium. Recordings on DiI+GFP cells were conducted 29 days later. Recordings were made at 30°C in a submersion chamber perfused at 3 ml/min with artificial cerebrospinal fluid (ACSF) containing: 119 mM NaCl, 2.5 mM KCl, 26 mM NaHCO3, 1 mM NaH2PO4, 11 mM D-Glucose, 3 mM CaCl2, and 2 mM MgCl2 at pH 7.28, 300 mOsm and saturated with 95%O2/5%CO2. Whole-cell recordings were performed on induced neurons using recording pipettes (~3-5 MΩ) filled with an intracellular solution containing: 0.2 mM EGTA, 130 mM K-Gluconate, 6 mM KCl, 3 mM NaCl, 10 mM HEPES, 4 mM ATP-Mg, 0.4 mM GTP-Na, 14 mM phosphocreatine-Tris at pH7.2 (adjusted by KOH) and 285 mOsm. For GABA and glycine puffing experiments, patch recording pipettes were filled with an intracellular solution containing: 135 mM KCl, 5 mM EGTA, 0.5 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 4 mM ATP-Mg, 0.4 mM GTP-Na, 14 mM phosphocreatine-Tris at pH 7.2 and 285 mOsm. Series and input resistance were measured in voltage clamp with a 400ms, 10 mV step from a −60 mV holding potential (filtered at 30 kHz, sampled at 50 kHz). Cells were only used for analysis if the series resistance was less than 30 MΩ and was stable throughout the experiment. Input resistance ranged from 0.6-2 GΩ. Currents were filtered at 3 kHz, acquired and digitized at 10 kHz on a PC using custom software (Labview; National Instruments). Action potentials were recorded in current clamp and elicited by aseries of current injections ranging from −20pA to 200pA at 20pA increments and 400ms in duration. Sodium currents were recorded in voltage clamp in response to a series of voltage stepsranging from −80mV to 20mV at 10mV increments and 100ms in duration according to standard protocols. TTX (1μM), a voltage-dependent Na+ channel blocker, was then applied to the chamber for 8 minutes and the voltage step was repeated to observe the TTX-sensitive currents. GABA, glycine or kainate (1μM each) were dissolved in ACSF and puffed onto neurons using a picospritzer III (Parker Instrumentation) with 6-9psi and 100ms duration for GABA and glycine or 800ms duration for kainate. The puffing pipette tip was ~3 MΩ and placed ~10μm away from the recorded neuron. Induced neurons (identified by GFP or DiI) were co-cultured with mouse cortical neurons for the recording of spontaneous activities. Spontaneous activities were recorded in voltage clamp. Currents elicited by neurotransmitter puffs were measured in voltage clamp for 6-10s. In all voltage clamp recordings, cells were clamped at −60mV except during the voltage step protocol. In all current clamp recordings, recordings were made at resting membrane potential or without any current injection. Data analysis was performed in LabView.

Myotube - hiCN coculture and live-cell imaging

C2C12 myoblasts (ATCC) were expanded in DMEM supplemented with 20% FBS and then induced to form multinucleated myotubes by switching to medium containing 5% horse serum (Sigma). Purified hiCNs were then plated onto the myotube culture in C2 medium to induce the formation of neuromuscular junctions and myotube contractions. Live-cell imaging was performed using a Deltavision Deconvolution Microscope or an AMG EVOS Digital Inverted Microscope. Curare (tubocurarine hydrochloride, 50 μM, Sigma) was applied as indicated to block hiCN-induced rhythmic contraction. Neuromuscular junctions were visualized by confocal laser scanning microscopy after labeling with rhodamine-conjugated α-bungarotoxin (α-BTX) (Invitrogen, 1:500) and immunostaining of SYT1 (DSHB, 1:200) and GFP (Invitrogen, 1:1000).

Statistical analysis

All experiments were performed in triplicate at least twice unless otherwise indicated. Data are presented as mean ± s.e.m. Statistical significance of differences between groups was determined using a two-tailed unpaired Student’s t-test. A P value of <0.05 was considered significant.

Supplementary Material



We thank the members of the Zhang lab for discussions and reagents. We also thank Eric Olson, Jane Johnson, and Derek Smith for critical reading of the manuscript. C.-L.Z. is a W. W. Caruth, Jr. Scholar in Biomedical Research. This work was supported by the Whitehall Foundation Award (2009-12-05), the Welch Foundation Award (I-1724), The Ellison Medical Foundation Award (AG-NS-0753-11), and NIH Grants (1DP2OD006484 and R01NS070981; to C.-L.Z.).


Author Contributions. M.L. and C.-L.Z. conceived and designed experiments; M.L., T.Z., Y.Z., and J.C. performed experiments; M.L., T.Z., J.G., K.H., and C.-L.Z. analyzed data; M.L. and C.-L.Z. wrote the manuscript; all authors commented on the manuscript.

The authors have no competing financial interests.

Accession Codes: Microarray data have been deposited in Gene Expression Omnibus with accession codes GSE45954.


1. Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell. 2010;143:508–525. [PMC free article] [PubMed]
2. Ladewig J, et al. Small molecules enable highly efficient neuronal conversion of human fibroblasts. Nat. Methods. 2012;9:575–578. [PubMed]
3. Marro S, et al. Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell Stem Cell. 2011;9:374–382. [PMC free article] [PubMed]
4. Son EY, et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell. 2011;9:205–218. [PMC free article] [PubMed]
5. Caiazzo M, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 2011;476:224–227. [PubMed]
6. Pfisterer U, et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl Acad. Sci. USA. 2011;108:10343–10348. [PubMed]
7. Vierbuchen T, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463:1035–1041. [PMC free article] [PubMed]
8. Ambasudhan R, et al. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell. 2011;9:113–118. [PMC free article] [PubMed]
9. Qiang L, et al. Directed conversion of Alzheimer’s disease patient skin fibroblasts into functional neurons. Cell. 2011;146:359–371. [PMC free article] [PubMed]
10. Pang ZP, et al. Induction of human neuronal cells by defined transcription factors. Nature. 2011;476:220–223. [PMC free article] [PubMed]
11. Liu X, et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell research. 2012;22:321–332. [PMC free article] [PubMed]
12. Kim J, et al. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell. 2011;9:413–419. [PMC free article] [PubMed]
13. Yoo AS, et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011;476:228–231. [PMC free article] [PubMed]
14. Heinrich C, et al. Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol. 2010;8:e1000373. [PMC free article] [PubMed]
15. Meng F, et al. Induction of fibroblasts to neurons through adenoviral gene delivery. Cell Res. 2012;22:436–440. [PMC free article] [PubMed]
16. Mizuguchi R, et al. Combinatorial roles of olig2 and neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons. Neuron. 2001;31:757–771. [PubMed]
17. Sun Y, et al. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell. 2001;104:365–376. [PubMed]
18. Ross SE, Greenberg ME, Stiles CD. Basic helix-loop-helix factors in cortical development. Neuron. 2003;39:13–25. [PubMed]
19. Lee S, Lee B, Lee JW, Lee SK. Retinoid signaling and neurogenin2 function are coupled for the specification of spinal motor neurons through a chromatin modifier CBP. Neuron. 2009;62:641–654. [PMC free article] [PubMed]
20. Scardigli R, Schuurmans C, Gradwohl G, Guillemot F. Crossregulation between Neurogenin2 and pathways specifying neuronal identity in the spinal cord. Neuron. 2001;31:203–217. [PubMed]
21. Ma YC, et al. Regulation of motor neuron specification by phosphorylation of neurogenin 2. Neuron. 2008;58:65–77. [PMC free article] [PubMed]
22. Lee SK, Pfaff SL. Synchronization of neurogenesis and motor neuron specification by direct coupling of bHLH and homeodomain transcription factors. Neuron. 2003;38:731–745. [PubMed]
23. Rouaux C, Arlotta P. Fezf2 directs the differentiation of corticofugal neurons from striatal progenitors in vivo. Nat. Neurosci. 2010;13:1345–1347. [PMC free article] [PubMed]
24. Chen B, et al. The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex. Proc. Natl Acad. Sci. USA. 2008;105:11382–11387. [PubMed]
25. Peljto M, Dasen JS, Mazzoni EO, Jessell TM, Wichterle H. Functional diversity of ESC-derived motor neuron subtypes revealed through intraspinal transplantation. Cell Stem Cell. 2010;7:355–366. [PMC free article] [PubMed]
26. Dasen JS, De Camilli A, Wang B, Tucker PW, Jessell TM. Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1. Cell. 2008;134:304–316. [PubMed]
27. Dasen JS, Liu JP, Jessell TM. Motor neuron columnar fate imposed by sequential phases of Hox-c activity. Nature. 2003;425:926–933. [PubMed]
28. Dasen JS, Tice BC, Brenner-Morton S, Jessell TM. A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. Cell. 2005;123:477–491. [PubMed]
29. Hester ME, et al. Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes. Mol. Ther. 2011;19:1905–1912. [PubMed]
30. Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell. 2002;110:385–397. [PubMed]
31. Thein DC, et al. The closely related transcription factors Sox4 and Sox11 function as survival factors during spinal cord development. J. Neurochem. 2010;115:131–141. [PMC free article] [PubMed]
32. Grothe C, Wewetzer K, Lagrange A, Unsicker K. Effects of basic fibroblast growth factor on survival and choline acetyltransferase development of spinal cord neurons. Brain Res. Dev. Brain Res. 1991;62:257–261. [PubMed]
33. Hughes RA, Sendtner M, Thoenen H. Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J. Neurosci. Res. 1993;36:663–671. [PubMed]
34. Teng YD, Mocchetti I, Taveira-DaSilva AM, Gillis RA, Wrathall JR. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J. Neurosci. 1999;19:7037–7047. [PubMed]
35. Mu L, et al. SoxC transcription factors are required for neuronal differentiation in adult hippocampal neurogenesis. J. Neurosci. 2012;32:3067–3080. [PMC free article] [PubMed]
36. Shim S, Kwan KY, Li M, Lefebvre V, Sestan N. Cis-regulatory control of corticospinal system development and evolution. Nature. 2012;486:74–79. [PMC free article] [PubMed]
37. Jordan PM, et al. Generation of spinal motor neurons from human fetal brain-derived neural stem cells: role of basic fibroblast growth factor. J. Neurosci. Res. 2009;87:318–332. [PMC free article] [PubMed]
38. Jo AY, Park CH, Aizawa S, Lee SH. Contrasting and brain region-specific roles of neurogenin2 and mash1 in GABAergic neuron differentiation in vitro. Exp. Cell Res. 2007;313:4066–4081. [PubMed]
39. Parras CM, et al. Divergent functions of the proneural genes Mash1 and Ngn2 in the specification of neuronal subtype identity. Genes Dev. 2002;16:324–338. [PubMed]
40. Bergsland M, Werme M, Malewicz M, Perlmann T, Muhr J. The establishment of neuronal properties is controlled by Sox4 and Sox11. Genes Dev. 2006;20:3475–3486. [PubMed]
41. Mu L, et al. SoxC transcription factors are required for neuronal differentiation in adult hippocampal neurogenesis. J. Neurosci. 2012;32:3067–3080. [PMC free article] [PubMed]
42. Thein DC, et al. The closely related transcription factors Sox4 and Sox11 function as survival factors during spinal cord development. J. Neurochem. 2010;115:131–141. [PMC free article] [PubMed]
43. Lee SK, Pfaff SL. Transcriptional networks regulating neuronal identity in the developing spinal cord. Nat. Neurosci. 2001;(4 Suppl):1183–1191. [PubMed]
44. Kim J, et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl Acad. Sci. USA. 2011;108:7838–7843. [PubMed]
45. Ring KL, et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell. 2012;11:100–109. [PMC free article] [PubMed]
46. Han DW, et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell. 2012;10:465–472. [PubMed]
47. Lujan E, Chanda S, Ahlenius H, Sudhof TC, Wernig M. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl Acad. Sci. USA. 2012;109:2527–2532. [PubMed]
48. Thier M, et al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell. 2012;10:473–479. [PubMed]
49. Niu W, Zou Y, Shen C, Zhang CL. Activation of postnatal neural stem cells requires nuclear receptor TLX. J. Neurosci. 2011;31:13816–13828. [PMC free article] [PubMed]